Stay updated on Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Footer updates: added 'Revision: v3.3.3'; removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.
    Difference
    0.1%
    Check dated 2025-12-17T17:47:33.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Publication descriptions were updated to clarify that listed publications are provided voluntarily and are automatically filled from PubMed, and a new revision tag v3.3.2 was added.
    Difference
    0.2%
    Check dated 2025-11-26T07:40:50.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The government funding lapse notice was removed from the page, eliminating the banner that previously directed users to opm.gov for status updates.
    Difference
    0.4%
    Check dated 2025-11-19T08:26:38.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added the Results section for KEYNOTE-087 with primary and secondary outcome measures and cohort-specific analyses (ORR, PFS, DOR, OS, etc.), along with a Publications subsection listing related articles. This update includes the final study results and associated literature.
    Difference
    0.4%
    Check dated 2025-10-28T05:19:16.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    - Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T16:04:32.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Update to bibliographic metadata: upgrade the citation to v3.1.0 and removal of an explicit erratum reference, indicating a versioned citation change with no new content added.
    Difference
    0.3%
    Check dated 2025-09-29T10:00:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Relapsed Hodgkin Lymphoma Clinical Trial page.